comparison of 2 medicines: Melatonin and Triclofos to achieve sleep for EEG
Not Applicable
Completed
- Conditions
- Health Condition 1: G409- Epilepsy, unspecified
- Registration Number
- CTRI/2019/01/016917
- Lead Sponsor
- Bharati Hospital research Centre Pune
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 228
Inclusion Criteria
Al children coming for EEG who meet the age criteria
Exclusion Criteria
Children with acute illness, chronic heart disease, hepatic or renal disease, myopathy or had a prior complication on sedation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Number of EEG successfully completed <br/ ><br>2. Sleep onset latency <br/ ><br>3. Period of sleep <br/ ><br>4. Incidence of adverse eventsTimepoint: 1. Number of EEG successfully completed at the end of procedure, usually half an hour <br/ ><br>2. Sleep onset latency in minutes after onset of EEG procedure <br/ ><br>3. Period of sleep in minutes, during and fater EEG <br/ ><br> <br/ ><br> <br/ ><br>4. Incidence of adverse events within first 24 hours of drug administration
- Secondary Outcome Measures
Name Time Method 1. Yield of epileptiform discharges on EEG <br/ ><br>2. Need for second dose to achieve sedation <br/ ><br>3. Artifacts in EEGTimepoint: Till successful completion of EEG